El Salvador vs Laos: Antiretroviral therapy coverage for PMTCT
El Salvador
66.0%
in 2024
Laos
68.0%
in 2024
El Salvador rank
56th
Laos rank
54th
Antiretroviral therapy coverage for PMTCT over time
- El Salvador
- Laos
How they compare
Laos currently reports 68.0% against 66.0% in El Salvador, a difference of 2.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Laos ahead.
El Salvador ranks 56th and Laos ranks 54th of 84 countries.
El Salvador has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | El Salvador | Laos | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 43.6% | 4.2% | 39.4% | El Salvador |
| 2010s | 73.8% | 20.2% | 53.6% | El Salvador |
| 2020s | 81.0% | 44.8% | 36.2% | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, El Salvador or Laos?
- Laos, at 68.0% against 66.0% in El Salvador as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between El Salvador and Laos?
- 2.0%, with Laos ahead.
- How many years of comparable data are there for El Salvador and Laos?
- 25 years are reported by both, from 2000 to 2024.
- How do El Salvador and Laos rank globally for antiretroviral therapy coverage for pmtct?
- El Salvador ranks 56th and Laos ranks 54th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).